Header Logo

Connection

AMIR SHARAFKHANEH to Pulmonary Disease, Chronic Obstructive

Back to Details
This is a "connection" page, showing publications AMIR SHARAFKHANEH has written about Pulmonary Disease, Chronic Obstructive.
AMIR SHARAFKHANEH
Connection Strength
5.308
Pulmonary Disease, Chronic Obstructive
  1. Identification of sleep phenotypes in COPD using machine learning-based cluster analysis. Respir Med. 2024 06; 227:107641.
    View in: PubMed
    Score: 0.514
  2. Obesity modulates diaphragm curvature in subjects with and without COPD. Am J Physiol Regul Integr Comp Physiol. 2017 Nov 01; 313(5):R620-R629.
    View in: PubMed
    Score: 0.324
  3. Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia. COPD. 2017 08; 14(4):462.
    View in: PubMed
    Score: 0.319
  4. Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia. COPD. 2017 02; 14(1):23-29.
    View in: PubMed
    Score: 0.303
  5. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20.
    View in: PubMed
    Score: 0.260
  6. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92.
    View in: PubMed
    Score: 0.238
  7. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. Respir Med. 2012 Feb; 106(2):257-68.
    View in: PubMed
    Score: 0.216
  8. COPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606.
    View in: PubMed
    Score: 0.201
  9. Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66.
    View in: PubMed
    Score: 0.201
  10. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.
    View in: PubMed
    Score: 0.195
  11. Sleep disorders and their management in patients with COPD. Ther Adv Respir Dis. 2009 Dec; 3(6):309-18.
    View in: PubMed
    Score: 0.188
  12. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 May 01; 5(4):513-8.
    View in: PubMed
    Score: 0.169
  13. Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii.
    View in: PubMed
    Score: 0.162
  14. The confounding effects of thoracic gas compression on measurement of acute bronchodilator response. Am J Respir Crit Care Med. 2007 Feb 15; 175(4):330-5.
    View in: PubMed
    Score: 0.153
  15. Telehealth pulmonary rehabilitation enhances functional capacity and quality of life in veterans with chronic obstructive pulmonary disease: a 12-week single-arm intervention study. Sci Rep. 2025 Nov 28; 15(1):43118.
    View in: PubMed
    Score: 0.143
  16. Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery. Thorax. 2005 Apr; 60(4):288-92.
    View in: PubMed
    Score: 0.137
  17. The Saga of COVID-19 in Chronic Lung Disease: History Repeats Itself. Ann Am Thorac Soc. 2024 07; 21(7):1001-1002.
    View in: PubMed
    Score: 0.130
  18. Novel method for measuring effects of gas compression on expiratory flow. Am J Physiol Regul Integr Comp Physiol. 2004 Aug; 287(2):R479-84.
    View in: PubMed
    Score: 0.128
  19. Harnessing Digital Health to Objectively Assess Functional Performance in Veterans with Chronic Obstructive Pulmonary Disease. Gerontology. 2022; 68(7):829-839.
    View in: PubMed
    Score: 0.109
  20. Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons. Pharmacoepidemiol Drug Saf. 2019 02; 28(2):140-147.
    View in: PubMed
    Score: 0.086
  21. Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population. COPD. 2017 Oct; 14(5):484-489.
    View in: PubMed
    Score: 0.080
  22. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 07; 13(7):1016-25.
    View in: PubMed
    Score: 0.075
  23. The asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509.
    View in: PubMed
    Score: 0.068
  24. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014 Oct; 146(4):941-950.
    View in: PubMed
    Score: 0.066
  25. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr. 2013 Nov 01; 64(3):271-8.
    View in: PubMed
    Score: 0.062
  26. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1747-1754.
    View in: PubMed
    Score: 0.058
  27. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012 Aug 23; 10:100.
    View in: PubMed
    Score: 0.057
  28. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012 May 15; 156(10):673-83.
    View in: PubMed
    Score: 0.056
  29. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9.
    View in: PubMed
    Score: 0.055
  30. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.
    View in: PubMed
    Score: 0.051
  31. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. J Breath Res. 2011 Mar; 5(1):016003.
    View in: PubMed
    Score: 0.051
  32. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):604-11.
    View in: PubMed
    Score: 0.050
  33. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2009 Dec; 22(6):587-92.
    View in: PubMed
    Score: 0.047
  34. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207.
    View in: PubMed
    Score: 0.046
  35. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. Pulm Pharmacol Ther. 2009 Feb; 22(1):44-9.
    View in: PubMed
    Score: 0.044
  36. Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease. COPD. 2008 Feb; 5(1):35-41.
    View in: PubMed
    Score: 0.042
  37. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008 Mar; 38(3):385-96.
    View in: PubMed
    Score: 0.041
  38. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med. 2007 Sep 01; 176(5):454-9.
    View in: PubMed
    Score: 0.040
  39. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007 Jan; 131(1):20-8.
    View in: PubMed
    Score: 0.039
  40. Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006 Aug; 3(6):533-4.
    View in: PubMed
    Score: 0.038
  41. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006 Jul-Aug; 47(4):312-9.
    View in: PubMed
    Score: 0.037
  42. Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.